Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 6-MTH group results

Nov 8 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2024        Sep 30, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             19.76               19.12            48.90    
                 (+3.4 pct)          (-41.3 pct)      (+12.4 pct) 
  Operating        417 mln               1.41             5.00    
                 (-70.4 pct)         (-87.0 pct)      (+66.5 pct) 
  Recurring        549 mln               1.60             5.20    
                 (-65.6 pct)         (-85.4 pct)      (+52.7 pct) 
  Net              513 mln               1.08             3.40    
                 (-52.7 pct)         (-87.3 pct)     (+129.6 pct) 
  EPS             4.26 yen            9.00 yen         28.24 yen  
  Ann Div                             17.00 yen        17.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             17.00 yen        17.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news